PR‐DUB safeguards Polycomb repression through H2AK119ub1 restriction
Cell Proliferation · 2023
DOI: 10.1111/cpr.13457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2023. Verfasst von Rui Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key …. Hauptthemen laut MEDLINE: Histones, Drosophila Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research Project of Tianjin Education Commission, National Key Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Polycomb group (PcG) proteins are critical chromatin regulators for cell fate control. The mono‐ubiquitylation on histone H2AK119 (H2AK119ub1) is one of the well‐recognized mechanisms for Polycomb repressive complex 1 (PRC1)‐mediated transcription repression. Unexpectedly, the specific H2AK119 deubiquitylation complex composed by additional sex comb‐like proteins and BAP1 has also been genetically characterized as Polycomb repressive deubiquitnase (PR‐DUB) for unclear reasons. However, it remains a mystery whether and how PR‐DUB deficiency affects chromatin states and cell fates through impaired PcG silencing. Here through a careful epigenomic analysis, we demonstrate that a bulk of H2AK119ub1 is diffusely distributed away from promoter regions and their enrichment is positively correlated with PRC1 occupancy. Upon deletion of Asxl2 in mouse embryonic stem cells (ESCs), a pervasive gain of H2AK119ub1 is coincident with increased PRC1 sampling at chromatin. Accordingly, PRC1 is significantly lost from a subset of highly occupied promoters, leading to impaired silencing of associated genes before and after lineage differentiation of Asxl2 ‐null ESCs. Therefore, our study highlights the importance of genome‐wide H2AK119ub1 restriction by PR‐DUB in safeguarding robust PRC1 deposition and its roles in developmental regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Educati…
- Wuxi School of Medicine, Jiangnan University, Wuxi, 214000, China.
- Pediatric Center, Tianjin Key Laboratory of Epigenetics for Organ Development of Premature Infants, The Fifth Central Hospital of Tianjin, Tianjin, 300450, China.
- Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
- The Institute of Cancer Research (ICR), London, UK.
- Department of Bioinformatics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
ORCID-Profile: Xudong Wu
Förderung
- Key Research Project of Tianjin Education Commission
- National Key Research and Development Program
- National Natural Science Foundation of China
- National Youth Talent Support Program
- the National Key Research and Development Project of Stem Cell and Transformation Research
- Tianjin Medical University Talent Excellence Program
- National Key Research and Development Program of China
Zitieren
APA
Li, R., Huang, D., Zhao, Y., Yuan, Y., Sun, X., Dai, Z., Huo, D., Liu, X., Helin, K., Li, M. J., & Wu, X. (2023). PR‐DUB safeguards Polycomb repression through H2AK119ub1 restriction. Cell Proliferation. https://doi.org/10.1111/cpr.13457
Vancouver
Li R, Huang D, Zhao Y, Yuan Y, Sun X, Dai Z, et al. PR‐DUB safeguards Polycomb repression through H2AK119ub1 restriction. Cell Proliferation. 2023. doi:10.1111/cpr.13457
BibTeX
@article{Li2023,
author = {Li, Rui and Huang, Dandan and Zhao, Yingying and Yuan, Ye and Sun, Xiaoyu and Dai, Zhongye and Huo, Dawei and Liu, Xiaozhi and Helin, Kristian and Li, Mulin Jun and Wu, Xudong},
title = {PR‐DUB safeguards Polycomb repression through H2AK119ub1 restriction},
journal = {Cell Proliferation},
year = {2023},
doi = {10.1111/cpr.13457}
}
EUVIMED